John Thero
Director/Board Member chez CYTEIR THERAPEUTICS, INC.
Fortune : 70 995 $ au 29/02/2024
Profil
John F.
Thero currently works at Cyteir Therapeutics, Inc., as Independent Director from 2022.
Mr. Thero also formerly worked at Amarin Corp.
Plc, as President, Chief Executive Officer & Director from 2014 to 2021, Amarin Pharma, Inc., as President, CEO, Treasurer & Director, Chiasma, Inc., as Independent Director from 2015 to 2021, CinCor Pharma, Inc., as Independent Director from 2021 to 2023, ABIOMED, Inc., as Chief Financial Officer, Treasurer & Senior VP from 1994 to 2003, Revvity, Inc., as Chief Financial Officer, Acusphere, Inc., as Chief Financial Officer, Secretary & Treasurer from 2003 to 2007, ViaCell, Inc., as Chief Financial Officer, and Aries Technology, Inc., as Chief Financial Officer from 1987 to 1992.
Mr. Thero received his undergraduate degree from College of the Holy Cross (Massachusetts).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/02/2024 | 22 828 ( 0,06% ) | 70 995 $ | 29/02/2024 |
Postes actifs de John Thero
| Sociétés | Poste | Début |
|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Director/Board Member | 04/02/2022 |
Anciens postes connus de John Thero
| Sociétés | Poste | Fin |
|---|---|---|
| CINCOR PHARMA, INC. | Director/Board Member | 24/02/2023 |
| CHIASMA, INC. | Director/Board Member | 05/08/2021 |
| AMARIN CORPORATION PLC | Chief Executive Officer | 01/08/2021 |
| ACUSPHERE, INC. | Director of Finance/CFO | 30/06/2007 |
| ABIOMED, INC. | Director of Finance/CFO | 01/01/2003 |
Formation de John Thero
| College of the Holy Cross (Massachusetts) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| AMARIN CORPORATION PLC | Health Technology |
| REVVITY, INC. | Health Technology |
| ACUSPHERE, INC. | Health Technology |
| CYTEIR THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
ABIOMED, Inc.
 ABIOMED, Inc. Medical SpecialtiesHealth Technology ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA. | Health Technology |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Needham, MA. | Health Technology |
Aries Technology, Inc.
 Aries Technology, Inc. Information Technology ServicesTechnology Services Aries Technology, Inc. develops and implements multimedia curriculum and services. Its e-learning solutions offer educational and administrative tools for teachers, students, administrators, and parents. The firm offers information technology courses in the areas of hardware maintenance and repair, networking, Linux essentials and personal computer technology in English and Spanish languages. Aries Technology was founded in 1986 and is headquartered in Tempe, AZ. | Technology Services |
Amarin Pharma, Inc.
 Amarin Pharma, Inc. Pharmaceuticals: MajorHealth Technology Amarin Pharma, Inc. operates as a biopharmaceutical research company. The company was founded in 2007 and is headquartered in Bedminster, NJ. | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
